Anda di halaman 1dari 61

MASTER COPY

EVALUASI INDEPENDEN CAKUPAN


IMUNISASI MR (MR CAMPAIGN) DI 6
PROVINSI DI PULAU JAWA TAHUN 2017:
"EVALUATION OF MEASLES RUBELLA (MR)
IMMUNIZATION CAMPAIGN VACCINATION
COVERAGE IN DIY PROVINCE"

Department of Epidemiology and Tropical Diseases,


Faculty of Public Health, Diponegoro University

2018

1
Executive Summary
The Expanded Program on Immunization (EPI) is a health intervention
program designed by World Health Organization (WHO) in response to
the high infant morbidity and mortality due to infectious diseases. WHO
recommends immunization strategies to all countries through EPI program.
Indonesia had committed and adopted the goal of measles elimination and
rubella/CRS control in South East Asia Region by 2020. Mass vaccination
campaigns are considered an important strategy to increase vaccine coverage.
MR campaign had been done in all provinces in Java Island (West Java,
Banten, DKI Jakarta, DI Yogyakarta, Central Java and East java) on
A u g u s t - September 2017. In 2018 the MR campaign will be conducted for
all provinces out of Java Island for all rest of provinces in Indonesia.
However, before the MR campaign out Java island, evaluation of MR
campaign in Java island may be conducted in order to know the real MR
immunization coverage in the population and the obstacles during MR
campaign in the field at all provinces at Java Island. This study using cross
sectional study design combine between quantitative (province coverage
survey) and qualitative approach (Rapid Assessment Procedure (RAP). The
survey (coverage survey) using WHO followed WHO manual for
Immunization Coverage Survey 2015 to describe immunization coverage
in DIY Province. The qualitative approach will used in-depth interview,
observation and secondary data collection in order to know the obstacles
during MR campaign at DIY Province. The coverage evaluation survey will
help better plan for the MR campaign in the rest of Indonesia scheduled for
2018.

2
1. Introduction

1.1 Backgrounds

The current epidemiology of measles and rubella in Indonesia reflects the progress
and challenges of the immunization program over time. Although immunization
against measles began more than 30 years ago, measles remained endemic until
recently.

Measles and rubella are vaccine preventable, viral diseases that have the potential to
harm non-immune pregnant women and their fetuses/neonates if exposure occurs.
The most concerning of these is rubella, as it can cause congenital rubella syndrome
(CRS) with devastating effects. Measles has long been a recognized public health
problem in Indonesia, but the burden of rubella and congenital rubella syndrome
(CRS) has been underappreciated until recently. 1–3

Measles and rubella are among the most infectious diseases of humans. High level of
herd immunity is required for its elimination. Sero-prevalence studies suggest that
coverage in the range of 90–95 % is needed. Measles and rubella are vaccine-
preventable diseases with similar symptoms and are frequently confused with each
other. Both viruses cause rash and fever. Measles can be deadly for children with
poor nutrition and weakened immune systems. Rubella is also very contagious but
causes relatively mild disease in children; in pregnant women, rubella can lead to
miscarriage or severe birth defects (congenital rubella syndrome), including
blindness, deafness, and heart problems. Rubella and measles are a public health
problem in poor countries in Africa and Asia, including Indonesia, where uptake of
the measles and rubella vaccine is relatively low and increasing access to
immunization through large scale vaccination campaigns can significantly reduce
deaths and illnesses.4–6

3
The Expanded Program on Immunization (EPI) is a health intervention program
designed by World Health Organization (WHO) in response to the high infant
morbidity and mortality due to infectious diseases. WHO recommends immunization
strategies to all countries through EPI program. Immunization of infants with
measles vaccine, tetanus toxoid, hepatitis B vaccine, OPV for Poliomyelitis and DTP
for diphtheria, pertussis, and tetanus are recommended to all countries. Indonesia
had been implementing basic immunization as national immunization program
formally since 1979. 7

Indonesia started with measles elimination since 2009 by conducting school


immuniation for measles and started with second doses measles in 2015. Those
immunization expectedly will reduce measles diseases infection in the country and
accelerate the measles elimination n the country. Measles school immunization
coverage was reported successfull with coverage more than 90%, but second dose
measles had still low coverage after two years program implemented.8

Several aims will be adressed to adopt the goal of measles elimination and
rubella/CRS control in South Eash Asia Region by 2020, such as achieve and
maintain at lease 95% population imunity with two dose againts measles and rubella
within each district of each country in region through routine/or supplementary
immunization, develop and sustain and timely case-based measles and rubella and
CRD surveillance sysstem in each country in the region that fulfils recommended
surveillance performance indicators, develop and maintain a WHO proficient
measels and rubella laboratory network that support every country in the region,
strengthen support and linkages to achieve the above three strategic objectives. 9–11

Indonesia had commited and adopted the goal of measles elimination and
rubella/CRS control in South Eash Asia Region by 2020. In order to achive measles
elimination by the year 2020 some activities will be done, which are:12–14
1. Indonesia has national measles elimination and rublella/CRS control by 2020
by conducting some objectives,which are: i)first dose measles coverage at leas

4
95% nationally and >90% subnational by 2018. ii) second dose vacinnation
coveage at least 95% in 2018
2. Measles campaign at high risk areas at the end of 2016 targeting children 9-59
month National MR Campaign in 2018- 2019 targeting 9 month – 15 years
3. Fully investigated all detected/reported measles outbreaks
4. Case based measles surveillance :
▪ 50% specimens tested by 2016 • 100 % specimen tested by 2020
5. CRS Surveillance initiated at selected hospital in 10 provinces in 2015 and
will be expanded to the remaining provinces in 2017 - 2019

Mass vaccination campaigns are considered an important strategy to increase


vaccine coverage. There is ongoing debate, however, regarding the potential for both
positive and negative consequences of mass vaccination programs, particularly
because of the targeted and time limited nature of elimination goals and resource
constraints. 3,15–17

MR campaign had been done in all provinces in Java island (West Java, Banten,
DKI Jakarta, DI Yogyakarta, Central Java and East java) on September 2017. In
2018 the MR campaign will be conducted for all provinces out of Java Island for all
rest of provinces in Indonesia. 8

Like other countries in Asia, measles-rubella (MR) vaccine coverage in Indonesia is


suboptimal whereas 90–95 % coverage is needed for elimination of these diseases.
Strategically, the MOH used both routine immunization centres and educational
8,18
institutions for providing vaccine to the children aged 9 months to <15 years.
The reported MR immunization coverage during the campaign at all provinces at
Java island was more than 95%.
Special Region of Yogyakarta (DIY) has 5 districts / cities there are Yogyakarta
City, Bantul Regency , Kulon Progo Regency, Gunung Kidul Regency, and Sleman
Regency. EPI immunization coverage for measless tends to increase. In 2016 the
coverage was 96.7%, while in 2017 was 97.1%. There was an increase Measles-

5
Rubella cases from 2016 to 2017 in DIY Province. The case of Rubella disease in
the Province of Yogyakarta has increased from 2016 cases by 486 cases (22%) from
2196 suspect to 789 cases (32%) from 2288 suspect in 2017. The highest case
increase occurred in Gunung Kidul District, which was 291 cases (61%) in 2017
originally in 2016 only 50 cases (17%).
MR immunization coverage 98.6% ( 760,145 immunized from 771,288 population
target). MR vaccination coverage in Kulon Progo, Gunung Kidul, Yogyakarta,
Sleman, and Bantul were 99.1%, 99.3%, 98.2%, 98.3%, and 98.3% respectively.
Main factor of MR immunization rejection is religion ( 3,243 cases). There were 4
AEFI cases validated by National Commision of AEFI.

However, before the MR campaign out Java island, evaluation of MR campaign in


Java island may be conducted in order to know the real MR immunization coverage
in the population and the obstacles during MR campaign in the field at all provinces
at Java island.

Vaccination coverage was estimated using the reported number of doses


administered divided by the target population. To validate the campaign coverage
determined by the administrative method, a coverage evaluation survey was
conducted within one-two month after campaign. 1,19–21 This evaluation (survey) will
help better plan for the MR campaign in the rest of Indonesia scheduled for 2018.

1.2 Objectives
1.2.1 General Objectives
To determine provincial MR immunization coverage among children 9 month to 15
years old at the time of the 2017 campaign in the community at DIY Province and to
know the several challenges of MR campaign in the field in order to report the
progress to date made toward measles and rubella elimination in Indonesia and the
implementation and results of measles–rubella (MR) vaccination campaigns
conducted in 2017 had a significant impact on measles and rubella cases.

6
In other words, to assess the impact of the measles rubella campaign activities on
improving population-level vaccine coverage, identify sub-group with lower
coverage, estimate coverage rates by subgroups, and identify reasons for vaccine
noncompliance or refusal.

Specific Objectives
i. Assess SIA MR Vaccination coverage by sex, rural/urban, length of residency
in the area and other demographic characteristics.
ii. Assess factors related to not receiving an MR vaccine during SIA
iii. Assess the proportion of children with zero MCB vaccination, the proportion
for whom the SIA vaccination was their first MCV and the proportion with at
least 1 and at least 2 MCV doses by age group.
iv. Assess the occurence of AEFI, systemic and local reactions, and those that
require medical consultation.
v. Have a qualitative assessment of the campaign among health workers, school,
and the community.
vi. Assess vaccination card (for RI) ever received and available.

1.3 Output of the Survey

i. Province MR survey and reported coverage for DIY Province.


ii. Factors associated with MR campaign implementation and its obstacles
during its planning and implementation.
iii. Disemination of Survey results in the province (local dissemination) and at
national level.

1.4 Time Frame of the Survey

The MR campaign in Java island was done at on September to October 2017. The
survey will be conducted on 20 June-31 August 2018.

7
1.5 The Location of Survey

The immunization coverage survey will be conducted in DIY Province. The results
of the survey will reflect the immunization coverage of MR immunization coverage
for it. The study will be located at DIY Province.

1.6 Organization
The survey will be organized by Public Heath Faculty of Diponegoro University at
Central Java province.

1.7 Limitation of the Study


• The survey is cross sectional survey, therefore this survey will describe current
situation.
• Immunization status of children will be assessed by interviewing mothers,
validated by record on registry at the school.
• Recall bias might occurred because the last MR campaign was conducted in
September 2017 and the survey will be conducted in 20 June- 31 August 2018.
• Using cluster sampling technique in coverage survey, might raise the
representativeness issue if the selected clusters accidentally clumped in a few
areas or if proper probability sampling techniques are not implemented.

1.8 Budget
Budget for the studies funded by WHO Indonesia collaborated with National
EPI program Center for Diseases Control MoH RI.

8
II. Conceptual Assessment andVariables

2.1. Conceptual Framework

The assessment conceptual framework follows Lawrence Green, health believed


models and performance framework as follow:

Health Belief Model


- Perceived susceptibility
- Perceived severity
- Perceived benefits
Predisposing Factors - Perceived barriers
- Self-efficacy Resources and Management
- age - Resources (human,
- education - Cues to action
budget, etc)
- Occupation - Planning
- Sosial economic - Implementation
Clients
- KAP - Supervision and Monev

Enabling Factors
- Vaccines avaibility Providers Immunization Quality of
- Access Services
- Quality of - Place of Services
imm.services - Skill of HP
- Logistic, etc
- etc
Reinforcing Factors
- Family support Immunization Program
- Community - Policy on Practices
support - MR Imunization
- HP support - Obstacles and
Challenges
- etc
Threat
- Side Effects
- Norms
- Religions values

Immunization Status
(coverage)
• MR immunization
Figure 2.1. Conceptual Framework

9
Based on the conceptual framework above, the immunization status of the children
affected by two factors which are: i) the children factors and ii)providers factors.
The children factors will be depended on four factors: predisposing, enabling,
reinforcing, and threat. Where the providers factors will be depended on: resource
and management, quality of immunization services and policy and obstacles in the
field during MR campaign. Predisposing factors include age, education,
employment, socioeconomic, KAP. Enabling factors include availability of vaccines,
access to health services, quality of immunization services. Reinforcing factors
include family support, community support, and HP support. While threat include
side effects, norms, and religious values. Where the providers factors will be
depended on: resource and management, quality of immunization services and
policy and obstacles in the field during MR campaign. In addition to a direct
relationship between encoded exposure and MR vaccination, it is plausible that
indirect effects occurred through HBM variables targeted by the campaign. The
HBM posits that people will take action to prevent illness if they regard themselves
as susceptible to a condition (perceived susceptibility). This refers to a person's
subjective perception of the risks of his or her health condition. In the case of
medical illness, these dimensions include acceptance of the diagnosis, personal
estimation of the presence of resusceptibilily, and susceptibilily to disease in
general.
If they believe it would have potentially serious consequences (perceived severity).
Feelings about the seriousness of a disease include the evaluation of clinical and
medical consequences (for example, death, disability, and illness) and possible
social consequences (such as effects on work, family life, and social relations).
If they believe that particular course of action available to them would reduce the
susceptibility or severity or lead to other positive outcome (perceived benefits). This
encourages to produce a supportive force toward behavioral change. This depends
on one's belief in the effectiveness of the various measures available in reducing the
threat of illness, or perceived benefits in taking such health endeavors.
But if they perceive few negative attributes related to the health action (perceived
barriers). Additionally, the belief that one can successfully complete the behavior of

10
interest despite considered barriers (self-efficacy). However, in actuality, self-
efficacy is rarely included in HBM studies. Although less investigated, the model
also suggests that specific cues, such as factors in one’s environment, can impact the
final action one takes regard to the action in immunization. These cues to action can
be internal or external, ranging from experiencing symptoms of an illness to
exposure to a campaign. Much like self-efficacy, cues to action have not been
systematically evaluated, particularly considering their often fleeting nature.22–24

2.2. Variables Information

2.3.1. Variables

Data included: status of MR vaccination among children, key demographic and


household socio-economic status (SES) data, demand-side constraints and
perceptions about the campaign.
All information (variables) will be gathered in this assessment are follow: Health
believe Models and Lawrence Green:

MR Immunization Status
• Status of MR immunization of children 9 months to less than 15 years old
during MR Campaign in Java island

Immunization Program
• Policy in immunization program practices at local areas
• Organization and the man power
• Obstacles in immunization program

Resources and Management


• Resources (man power, manuals, hardware and software, facilities, etc)
• Training on immunization
• Immunization program services activities

11
• Management of cold chains and logistics
• Recording and reporting of immunization

Quality of Services
• Process in immunization program services
• Place of services
• Skill of heath personels
• Hospitality of health personels
• Cost of services

Predisposing Factors
• Age of parent
• Education attainment of parent
• Knowledge, attitudes and practices (KAP) of parentmother or caregiver
• Social Economic, etc

Enabling Factors
• Vaccines avaibility
• Access
• Quality of imm.services

Reinforcing Factors
• Parent support
• Community support

Threat
• Side Effects Experiences
• Norms and Cultures
• Religions values
• Access

12
• Working mother
• Parental knowledge on Immunization benefit

13
III. Methods

3.1. Study Approach

This study using cross sectional study design combine between quantitative
(province coverage survey) and qualitative approach (Rapid Assessment Procedure
(RAP)). The survey (coverage survey) using WHO followed WHO manual for
Immunization Coverage Survey 20151 to describe immunization coverage in the
study areas. The qualitative approach will used indepth interview, observation and
secondary data collection in order to know the obstacles during MR campaign in
province level and among health workers in districts.

Both quantitative and qualitative evaluations were done after implementation of the
campaign. Quantitative data were presented with mean (standard deviation, SD) for
continuous variables and with proportion for categorical variables. The overall and
age- and sex-specific coverage rates were calculated for each region and then
combined. Categorical variables were compared by chi-square statistics. Multiple
logistic regression analysis were performed to estimate odds ratios (OR) and 95 %
confidence intervals (CI) of coverage associated with covariates, with adjustment for
other covariates. Qualitative data were analyzed using content analysis.

A. Quantitative Approach (Coverage Survey)


The immunization coverage survey use a cluster sampling technique which follows
WHO reference manual of immunization coverage cluster survey 2015. Sample for
the survey will be selected using urban/rural stratification in each province, and then
a three steps stage sampling design. Firstly, the study area (province) will be divided
into two strata (urban and rural). In each strata, urban or rural in each province, 30
clusters (villages and kelurahan) in each strata will be randomly selected using
probability proportional to estimated size (PPES). Then, in each selected cluster, a
list of households will be done by a separate team. From this list of HHs, xx
households will be randomly selected by the survey coordinators in the office (and

11
WHO, Immunization Coverage Cluster Survey-Reference manual 2015, Working Draft Updated
July 2015, WHO Document Production Services, Geneva, Switzerland, July 2015

14
not by field teams to avoid selection biases) as recommended by the 2015 WHO
Survey Manual. All selected HHs will be contacted, those with who have children 9
to 59 months of age and 5-15 years old will be selected randomly using ‘random
walk’ both at two strata (urban and rural) in each cluster interviewed. All
probabilities of selection (of clusters, of HHs in each cluster, and of eligible persons
among all those eligible in a HHs) will be collected to allow for calculating design
weights, plus the outcome of each HH visit to correct for non-response. This
information is needed to conduct weighted analysis, to ensure representativeness, as
recommended by the 2015 WHO Vaccination Coverage Survey Manual.

Province MR immunization coverage survey will be reflected by the prevalence of


immunized children 9-1512-59 months of age and children 5-15 years old (and also
total children 9 months to 15 years old) in the province . The MR immunization
status of children will be based on recall of the mothers/caregivers and the children
(especially for children 5-15 years old). Probing questions used as reminders for to
reduce the recall bias will be used in the survey. The reminder was ”Measles-
Rubella”, rubella vaccination and the ink used to the one finger and done during
September to October 2017. This immunization status, for measles-containing
vaccines in routine among children aged 9-59 months, will be compared with
register of immunization status at health centers

3.2. Location

The coverage survey will be conducted at DIY Province.

3.3. Population and Sample

Target population MR immunization coverage survey is children 9 months to 15


years old living at the province and target population of MR immunization coverage
survey is children 9 months to 15 years old and living at the DIY Province. The
population for each immunization coverage survey can be seen in the following
Table 3.1.

15
Table. 3.1. Population of Children Less than 15 years old for all Provinces
Provinces Children 0- Children 5- Children Total
4 y.o and 9 years old 10-15 Proportion
below years old CUF/%yo
above
DI 274,200 266,700 262,500
Yogyakarta 803,400 51,8

The samples in the survey are: the children 9-59 months to 15 years old living at the
selected clusters (villages and kelurahan) are the target population from which the
sample will be drawn. Proportion of children underfive compared to children 5 to 15
years old was 51,8%.

3.4. Sample Size

In WHO coverage cluster survey manual 2015, sample size may be calculated with
the specific formula of sample size for small proportion since the coverage of MR in
Java islands was more than 95%, therefore the proportion unvaccinated children
because very small, therefore, here the sample size may be calculated using the
formula. 25

By following WHO survey coverage 2015, the sample size is calculated by


identifying a set of five numbers to multiply together: A x B x C x D x E.19 . With
all parameters are explained below,
where: A= Number of strata
B= Sample size per stratum (the effective sample size)
C= Design effect (DEFF)
D= Average number of households you’ll need to visit
E=Expected non-response due to persons not being at home after at least two
revisits, or eligible person s who refuse to participate.

By considering urban and rural area in the DIY Province was vary according to MR
coverage, social economic status, education attaintment, etc, therefore in this

16
coverage survey 2 strata (urban and rural) was define in order to anticipate the
variation of urban and rural in DIY Province.
In order to calculate the Effective Sample Size (ESS) the formula from Fleis in
WHO manual for coverage survey is in the following:

where is the standard normal distribution evaluated at 1 – and is the desired


half-width of the confidence interval (for example, if you want the confidence
interval to be no wider than ± 10%, then d = 0.1). If ≤ 0.3, then is calculated
according to Table K, where p refers to the expected coverage proportion. If > 0.3
or if p is unknown, then use the conservative = 1.

ESS does not change for coverage levels between 30% and 70%. When the coverage
level is assumed to lie outside the interval [30%, 70%], then a value of < 1 could
be used to reduce the required effective sample size (see Table B-1 for examples).
Suppose a 2-sided 95% confidence interval is desired with ±6% precision (d = 0.06).
Also suppose that the coverage probability is expected to be around 95%. Using the
value: k = 4(0.95-0.06) (1-0.95+0.06) = 0.3916 by using the formula above then the
Efective Sample Size (ESS) was 131.

WHO also developed the sample calculation using excel software using the formula.
Using the excel software and considering some criterias (conservative considerations
for intracluster correlation (ICC) which relates to the design effect, ) in the sample
calculation this study come up with the results: Total sample (AxBxC) was 875 ,
total number of household to be visited 2,764 household to be visited (NcsxDxE) at
both stratum (urban and rural). Number of household for each statum (BxCxDxE)
was 1,382 household. Number of cluster per stratum 30 (for each urban and rural)
(BxC/m) and number of household per cluster (DxExm) = 48 and total cluster 60
clusters. In order to anticipate non response rate the sample size will be round up to
be 1500 for each strata. As results from both sample size consideration with
probability sampling and sample size with small proportion, then sample size in this

17
study 30 clusters for each strata (urban and rural) and and 50 household in each and
the total sample will be 3000 household.

Among children 12-59 months additional questioners for basic routine immunization
coverage will also be measure in this study. Therefore this population (children 9
months to 59 months) of age will be considered as different strata with children 5-15
years old.. Number sample of those agegroup in each strata will be proportionally in
each province, Therefore the number of sample for agegroup in each strata in each
province in the following Table:

Table. 3.3. Sample for Each Strata in DIY Provinc


No.Sampl Total
Strat No e per Sample Children Children 5-
Province a Cluster cluster (HHS) 1-4 y.o 15 y.o.
50
DIY
Urban 30 1500 723 777
50
Rural 30 1500 723 777

3.5. Province Coverage


The MR immunization coverage survey was done at all 6 provinces at Java islands.
The survey will follow WHO Immunization coverage cluster survey – Reference
manual.19 The survey methodology describe below:

3.5.1. Urban and Rural Srata

Urban in this coverage survey is all kelurahan (same with village at district)located
at all “cities” in each province. Rural is all villages located at all “districts” at each
province. City and district will be differentiate based on the Central Statistics Office
(BPS) data. Kelurahan and village will also be based on the BPS data in Indonesia.

18
Then all kelurahan will be stratified as urban village and all villages (desa) will be
stratified as rural strata. Thus in each province will be devided in to two group of
strata urban villages and rural village.

3.5.2. Sampling frames


The sampling frame for the survey in the province will be made up of based on list
of village midviwes data at desa (village and kelurahan and village and RW or
subvillage officer). All list of children households in the selected kelurahan (first
strata) and village (desa) (second strata) will be the sampling frame for the
secondary sampling units (population study) of this survey. The sampling frame for
the survey in the province will be made up of based on list of village midwives data
at desa (village and kelurahan and village and RW or subvillage officer. The list
analysis of those two age-group population dataset will be collected during data
collection will be presented 12-59 m and 5-15 years. The supervisor will be
responsible to the do listing of households in each selected cluster before during data
collection. If in the field the list is not available number of children under five and
number of children 5-15 y.o will be verified by head of village or health care then
the the children under five will be selected among randomly selected by range
between N/n of children. Where N is number of children undefive or children 5-15
y.o. and n is sample of children underfive or children 5-15 y.o sample size required
in the selected village/cluster.

3.5.3. Cluster (desa or kelurahan) selection


Survey clusters (desa and or kelurahan) were selected by systematic sampling with
probability proportional to estimated population size (PPES) as recommended one of
the options presented in the WHO Manual , . The survey protocol specified surveys
of 30 clusters using a desa as the primary sampling unit. Total number of children
for children 9-4912 months of age and 5-15 years old at each village and kelurahan
will be collected and considered as sampling fraction for each cluster latter on in the
analysis.

19
Provisions were will be made during the sampling with a list of additional desa to
replace sampled village (desa or kelurahan) that could not be surveyed for:
i. Insecurity
ii. Size in the case of very small islands
iii. “Non existence” of the desa (this can happen due to administrative changes
over time)
Any replacement will be well documented.

3.5.4. Sampling Selection


Following WHO, Vaccination Coverage Cluster Surveys: Reference Manual, World
Health Organization, Working draft, 2015 will be selected in two stages as follows:

i. Selection of the cluster (village).


All the villages in the province will be given a code number. It consists of several
digits, starting with district code number, followed by sub-district code number and
rank number of the villages. Then each village will have specific number of cluster
(village). Each village will be weighted based on the total population of the village.
Therefore the village which have high population will have bigger chance to be
randomly selected. Hence, the selection of cluster (village) uses Probability
Proportionate to Estimated Size (PPES) sampling. By using PPS the sampling
fraction of all clusters will be similar or proportionally to size of their population.
Using systematic random PPES sampling, 30 clusters (villages and kelurahan) in
each strata ( (urban and rural) will be randomly selected.

Table 3.4 Randomly Selected Villages in DIY Province (Rural Areas)


District Subdistrict No Village Number of
Population
1.
Temon Demen 1216
2.
Wates Bendungan 6158
KULON PROGO 3.
Panjatan Krembangan 4528
4.
Lendah Ngentakrejo 6598
5.
Pengasih Pengasih 8704

20
District Subdistrict No Village Number of
Population
6.
Nanggulan Donomulyo 5711
7.
Samigaluh Gerbosari 4109
8.
Kretek Tirtomulyo 6449
9.
Bantul Bantul 15587
10.
Imogiri Imogiri 3727
BANTUL
11.
Pleret Wonokromo 13404
12.
Banguntapan Tamanan 12954
13.
Kasihan Tirtonirmolo 23874
14.
Panggang Girikarto 3648
15.
Paliyan Pampang 2325
16.
Tepus Sumber wungu 5559
17.
Rongkop Pucanganom 3439
18.
Semanu Semanu 14931
GUNUNG 19.
KIDUL Karangmojo Bejiharjo 12532
20.
Wonosari Siraman 5343
21.
Playen Dengok 2271
22.
Patuk Nglegi 2766
23.
Gedang sari Serut 4828
24.
Ngawen Tancep 5539
25.
Moyudan Sumber agung 10724
26.
Godean Sidoluhur 9466
27.
Mlati Tlogoadi 11884
SLEMAN
28.
Prambanan Sambi rejo 5097
29.
Ngaglik Sinduharjo 19168
30.
Tempel Pondok rejo 5529

21
Table 3.5 Randomly Selected Kelurahan in DIY Province (Urban Areas)
District Subdistrict No Village Number of
Population
1.
Mantrijeron Gedongkiwo 12334
2.
Mantrijeron Mantrijeron 8719
3.
Kraton Panembahan 7328
4.
Kraton Kadipaten 5472
5.
Mergangsan Keparakan 8696
6.
Mergangsan Wirogunan 10937
7.
Umbulharjo Sorosutan 16012
8.
Umbulharjo Warungboto 11541
9.
Umbulharjo Tahunan 9834
10.
Umbulharjo Semaki 5271
11.
Kotagede Prenggan 10694
12.
Kotagede Purbayan 8973
13.
Kotagede Rejowinangun 11485
YOGYAKARTA Gondokusuman 14.
Baciro 12603
15.
Gondokusuman Klitren 10320
16.
Gondokusuman Kotabaru 2518
17.
Danurejan Suryatmajan 4266
18.
Danurejan Tegal panggung 7760
19.
Pakualaman Purwo kinanti 5186
20.
Pakualaman Gunung ketur 4130
21.
Gondomanan Ngupasan 4787
22.
Ngampilan Notoprajan 7468
23.
Wirobrajan Patangpuluhan 6172
24.
Wirobrajan Wirobrajan 9247
25.
Gedong tengen Pringgokusuman 10859
26.
Gedong tengen Sosromenduran 6326
27.
Jetis Gowongan 6656

22
District Subdistrict No Village Number of
Population
28.
Jetis Cokrodiningratan 7857
29.
Tegalrejo Bener 4916
30.
Tegalrejo Kricak 12393

ii. Selection of sample (Household)


After the 30 clusters (villages/kelurahan) for each strata (urban and rural), were
selected in the province, selection of 50 50 households in each cluster was will be
done after listing all HHs in the selected cluster. The random selection of the 50 HHs
will be done by the central team. All households in the selected clusters will be
visited and listed all their houshold members.

by simple random sampling from the llist of children under five and children 5-15
y.o. Or if the list not availabe random selection will be selected randomly by range
or interval that will be deetermined based on number of children under five and
children 5-15 y.o available at each selected cluster.
3.6. Selection of Respondents
Any of the following household residents were eligible for inclusion in the survey:
▪ Having children 9-59 months of age and children 5-<15 years old.
▪ Mother and caregiver of children is willing to be interviewed

3.7. Listing household for the survey:

Pre-selected household with eligible children then will be interviewed by


enumerators for their MR immunization status using the tools that had been
developed.

3.8. Revisit strategy:

Up to two revisits would be done as necessary to complete vaccination


questionnaires as fully and accurately as possible. If a respondent is not present at

23
the first visit, field team will make up to once more visits to meet them. If a
respondent is present at the first visit but the home-based record (for routine
vaccination) is not available, then field team will complete as much of the
questionnaire as possible at the first visit and do up to two more visits to review the
home-based record and complete the relevant section of the questionnaire. A ‘mop
up’ revisit is also planned to be conducted on weekends and holidays, especially in
the urban areas.

B. Qualitative Approach
3.9. Data Collection Methods

In qualitative approach, Rapid Assessment Procedure (RAP) was implementing to


explore the obstacles during MR campaign by conducting several data collection
method such as: in-depth interview, observation and secondary data analysis.

This assessment will provide a comprehensive overview of the province’s and


district’s obstacles during MR vaccination service during the campaign. The
assessment will focus on human resource issues (motivation factors, staff numbers,
performance, accessibility, quality of services, etc). Key informant interviews. A
total of 58 purposively selected key informant interviews (KIIs) were conducted
after the MR campaign, following coverage surveys at the national, district, and
facility levels. Issues explored through KII include: human resource and workload,
demand generation, and supply of vaccine and other related commodities supply.
We sampled key informants from national, district and sub-district levels.

3.10. Key Informants and Tools


All the information required in this assessment (the obstacle during the campaign)
will be gathered from some key informants in district and health center level use
several data collection methods. The details informants and data collection methods
can be seen in Table 2.1. belows:

24
Table 3.4. Key Informants and Data Collection Methods

N0 Level Data Collection Methods Tools


I Provinces Secondary data will be Check list of
collected at all level secondary data
1 Head of PHO In-depth interview Guideline for indept
2 EPI managers at PHO In-depth interview Guideline for indept
II District
1 Head of DHO In-depth interview Guideline for indept
2 EPI managers at DHO In-depth interview Guideline for indept
III Health Centers
1 Head of Health Center In-depth interview Guideline for indept
2 EPI programer at HC In-depth interview and Guideline for indept
observation and check list
3 Health Center’s In-depth interview Guideline for indept
Midwife
III Village
4 Health Cadres In-depth interview Guideline for indept
5 Village Midvives In-depth interview Guideline for indept
IV School
1 Teachers In-depth interview Guideline for indept
2 Students In-depth interview Guideline for indept

All key informants in province level will be interviewed, however for key
informants in district level, health centers and village will be selected purposively
based on some inlcusson criteria which are
- MR coverage (low, medium and high)
- Problem during MR campaign implementation (hard and low)
- Distance to capital city of province and or district
- Some other related condition to the MR campaign implementation

3.11. Data Managements


3.11.1. Respondents

Respondents in the survey are mothers/care giver whose eligible children were in the
HHs sampled in the survey. The mothers/care giver will be interviewed to gather
information related to the MR immunization status of the children.

25
All key informants at each level will be indepth interviewed regard to obstacles of
MR immunization during the campaign.

3.11.2. Interviewer

This study will be implemented through collaboration with Public Health Faculty,
Diponegoro University as Government University with DIY Health Province, All
District Health Office and Health Centre. Data collection in the field will be
conducted by Public Health Faculty, Diponegoro University and supervised by the
researchers and DIY Health Province officer. For DIY province 20 interviewers will
be recruited by researchers.

3.11.3. Training, Supervisors (Coordinators) and Interviewers


The researchers will be trained by national team and enumerators will be trained by
researchers and assisted by the national team. National team will be consisted
Consultant, WHO staff and National EPI porgam staff. The trainings will cover the
following aspects:
• Objectives of MR immunization coverage.
• The concept of using cluster survey for the survey
• Structure of data collection tools and purpose of each item included in the tools
• Roles and responsibilities of the field team members
• Experienced to interviewer mother of eligible children

3.11.4. Instruments

Instruments (questionnaires) for the survey will be developed by researchers and


consultant by adopting the questionnaires from WHO Reference Manual
Immunization Coverage Cluster Survey (annex H) and KPC (Knowledge Practice
Coverage for Maternal and Child Health) and some coverage survey had done in

26
Indonesia. The field tested will be held before used. The objectives of the field test
are:
• To determine whether the questions are understandably
• To determine whether interviewers understand the questions and instructions
• To determine the time needed to locate an eligible child or mother and the time
needed to gather information for one eligible child.
• To determine whether the team works are working smoothly
• To determine whether data collection tools allow for legible recording of data
as they are collected.

3.11.5. Data Collection

Data will be collected in 30 rural areas and 30 urban areas at DIY Province by
enumerators. Enumerators conducting interview with the mother of the children as
the study sample. Data from each enumerator will be cross-checked by the
supervisors in the field. Any inconsistencies or incomplete information will be dealt
with accordingly before leaving the area. Complete questionnaires will be cleaned
and entered into the computer by data programmers. Data entry will be double
checked by data encoder and data manager. Data analysis will be done for each
provinces, and then collated together as a description of the country.

All results of qualitative approach (indept interview, observation) will be written as


field reported. Field report will be translated to the matrix that tabulated by source of
information and the topics or contents according to the information required for the
study. Content analysis will be done to explore the obstacles of MR immunization
services during the campaign.

3.11.6. Data analysis


In the post-campaign survey, probability of selection of the EPI centres at provincial
level and the probability of successful interview at cluster level within divisions
varied (rural and urban), as such sampling weights (reciprocal of the selection

27
probability) were estimated to compute weighted cover-age rates for each division
and all divisions combined. Data were presented with mean (standard deviation, SD)
for continuous variables and with proportion for categorical variables. The overall
and age and sex-specific coverage rates were calculated for each division and then
combined. Categorical variables were compared by chi square statistics. Multiple
logistic regression analyses were performed to estimate odds ratios (OR) and 95 %
confidence intervals (CI) of coverage associated with covariates, with adjustment for
other covariates. Qualitative data were analyzed using content analysis.

3.11.7. Immunization Status of children


Immunization status of children in the survey will be determined by collecting MR
immunization status during the campaign. During the campaign all children after
immunized the health provider gived mark in the finger of children with ‘marking
ink’. Therefore to recall MR immunization status the interviews will use questions
about recall of a measles-rubella or rubella campaign, or recall of ink the marking
ink as recall. All children immunized will e regisered at immunization registration
book. There fore all immunization status of children by recall will be compared with
recorded one in the registeration book. During MR immunization campaign
immunization record had been done by immunization cards for children under five
and school of children had been recorded at student registration at school. All those
records will be verificated during data collection.

3.11.7. Data Analysis


All data analysis will use STATA version 9 in order to describe all indicator of the
survey. Vaccine Coverage Quality Indicators had been developed for MR
immunization coverage will be analized accordingly.

3.12. Quality Control


i. Preparatory
Province supervisors or coordinators are preparing the survey from: research permit
from local government, the questionnaires, and all kits required for the survey.

28
Advanced visit to the field will be done by province coordinators to socialize the
survey to the formal and informal community leaders. All enumerator will be trained
before data collection in order to give better understanding to the survey and all
instruments used in the survey.

ii. Data Collection


Province researchers will coordinate all field works activities such as: to help the
field team in determining the center of the area and supervise all field activities in
order to control the quality of data and to ensure that all field works will be done
properly.

iii. Field Works


All researchers will coordinate all field works activities such as: to help the field
team in determining the center of the area and supervise all field activities in order to
control the quality of field works and to ensure that all field works will be done
properly.

iv. Data quality control


Data will be cross checked by interviewers where one male interviewer will check
the questionnaire that has been gathered by female interviewer and vice versa. Prior
to data entry to the computer and analysis, the completeness and consistency of the
data will checked by supervisor (province coordinator).

3.13. Organization
Survey team from Public Health Faculty of Diponegoro University at Central Java.
The survey team will comprise of a team leader (project coordinator), principal
investigator, researchers, field coordinators (provincial and district coordinators),
enumerators, data manager, administration staff, and finance staff. Survey team are
from Faculty of Public Health Diponegoro University. The researcher had trained
in conducting Rapid Coverage Assessment Immunization 2013 held by University

29
of Indonesia and conducting crossectional study to assess cold chain design in
Public Health Centre in 3 District.
The survey team will comprise of a team leader (project coordinator), researchers,
field coordinators, enumerators and data manager.
Consultant : Dr. dr. Tri Ynis Miko Wahyono, M.Sc
Team leader : Lintang Dian Saraswati, SKM, M. Epid
Researcher : Praba Ginandjar, SKM, M. Biomed
Nissa Kusariana, SKM, M.Si
Data Manager : Putri Septyarini, SKM
Field Coordinator : 4 persons (TBD)
Enumerators : 20 persons (TBD)
Finance and Admin : Endang Sri Utami, SKM
Local counterpart : 4 persons (TBD)

3.14. Ethical Issues

Informed Consent will be implemented before interview with all the respondents.
Confidentiality of the data collected will be maintained in each university that
conducted the survey. Identifying personal information will be accessible only to the
essential staff (researchers).
Data will not be used in any publications, reports or media, without any permission
from WHO, National EPI program and researchers due to the survey will be funded
by WHO with collaborated with National EPI program. Hence, all the data and
report will be submitted to WHO and National EPI program who have full authority
to the the data and reports.

Ethical Approvals for the protocol will be submitted to ethical commitee of Public
Health Faculty of Diponegoro University.

IV. References

30
1. Baba K, Okuno Y, Tanaka-Taya K, Okabe N. Immunization coverage and
natural infection rates of vaccine-preventable diseases among children by
questionnaire survey in 2005 in Japan. Vaccine [Internet]. 2011 Apr 5 [cited
2018 Jan 24];29(16):3089–92. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20870055
2. Hisano M, Kato T, Inoue E, Sago H, Yamaguchi K. Evaluation of measles–
rubella vaccination for mothers in early puerperal phase. Vaccine [Internet].
2016 Feb 24 [cited 2018 Jan 24];34(9):1208–14. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/26801065
3. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney
F. Progress in Measles and Rubella Elimination in Iran. Pediatr Infect Dis J
[Internet]. 2007 Dec [cited 2018 Jan 24];26(12):1137–41. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18043452
4. Tharmaphornpilas P, Yoocharean P, Rasdjarmrearnsook A-O, Theamboonlers
A, Poovorawan Y. Seroprevalence of antibodies to measles, mumps, and
rubella among Thai population: evaluation of measles/MMR immunization
programme. J Health Popul Nutr [Internet]. 2009 Feb [cited 2017 Dec
25];27(1):80–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19248651
5. White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM. Measles,
mumps, and rubella. Clin Obstet Gynecol [Internet]. 2012 Jun [cited 2018 Jan
24];55(2):550–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22510638
6. Taneja D, Sharma P. Targeting rubella for elimination. Indian J Public Health
[Internet]. 2012 [cited 2018 Jan 24];56(4):269. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/23354136
7. World Health Organization. Global Programme for Vaccines and
Immunization: Expanded Programme on Immunization: Safe Vaccine
[Internet]. Geneva, Switzerland; 1998. Available from:
http://apps.who.int/iris/bitstream/10665/65204/1/WHO_GPV_98.04.pdf
8. CDC-MOH_RI. Profile of CDC Directorate Performance 2015. Jakarta; 2015.

31
9. Aaby P, Clements CJ. Measles immunization research: a review. Bull World
Health Organ [Internet]. 1989 [cited 2018 Jan 24];67(4):443–8. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/2680141
10. Stambos V, Leydon J, Riddell M, Clothier H, Catton M, Featherstone D, et al.
Evaluation of the World Health Organization Global Measles and Rubella
Quality Assurance Program, 2001–2008. J Infect Dis [Internet]. 2011 Jul
[cited 2018 Jan 24];204(suppl_1):S499–505. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21666206
11. Vashishtha VM, Yewale VN, Bansal CP, Mehta PJ, Indian Academy of
Pediatrics, Advisory Committee on Vaccines and Immunization Practices
(ACVIP). IAP perspectives on measles and rubella elimination strategies.
Indian Pediatr [Internet]. 2014 Sep [cited 2018 Jan 24];51(9):719–22.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/25228604
12. Uddin MJ, Adhikary G, Ali MW, Ahmed S, Shamsuzzaman M, Odell C, et al.
Evaluation of impact of measles rubella campaign on vaccination coverage
and routine immunization services in Bangladesh. BMC Infect Dis [Internet].
2016 Dec 12 [cited 2018 Jan 24];16(1):411. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/27519586
13. Bechini A, Levi M, Boccalini S, Tiscione E, Panatto D, Amicizia D, et al.
Progress in the elimination of measles and congenital rubella in Central Italy.
Hum Vaccin Immunother [Internet]. 2013 Mar [cited 2018 Jan 24];9(3):649–
56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23292174
14. Ihara T. The strategy for prevention of measles and rubella prevalence with
measles–rubella (MR) vaccine in Japan. Vaccine [Internet]. 2009 May 21
[cited 2018 Jan 24];27(24):3234–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19366578
15. Reichler MR, Darwish A, Stroh G, Stevenson J, Al Nasr MA, Oun SA, et al.
Cluster survey evaluation of coverage and risk factors for failure to be
immunized during the 1995 National Immunization Days in Egypt. Int J
Epidemiol [Internet]. 1998 Dec [cited 2018 Jan 24];27(6):1083–9. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/10024208

32
16. Salmaso S, Rota MC, Ciofi Degli Atti ML, Tozzi AE, Kreidl P. Infant
immunization coverage in Italy: estimates by simultaneous EPI cluster
surveys of regions. ICONA Study Group. Bull World Health Organ [Internet].
1999 [cited 2018 Jan 24];77(10):843–51. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10593033
17. Webber R. Communicable Disease Epidemiology and Control A Global
Perspective [Internet]. 2nd ed. Walingford Oxfordshire : CABI Publishing is a
division of CAB International CABI Publishing; 2005 [cited 2018 Jan 24].
32-74 p. Available from: http://www.harep.org/Agriculture/2005p.pdf
18. Ministry of Health Republic of Indonesia. Indonesia Health Profile, 2016.
Jakarta; 2016.
19. WHO. World Health Organization Vaccination Coverage Cluster Surveys:
Reference Manual [Internet]. Geneva; 2015 [cited 2018 Jan 24]. (version 3
updated July 2015). Available from:
http://www.who.int/immunization/monitoring_surveillance/Vaccination_cove
rage_cluster_survey_with_annexes.pdf
20. Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H,
Celestin E-P. The Use of Rapid Coverage Monitoring in the National Rubella
Vaccination Campaign, Haiti 2007–2008. J Infect Dis [Internet]. 2011 Sep 1
[cited 2018 Jan 24];204(suppl_2):S698–705. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21954269
21. Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE,
Chamouillet H, et al. Haiti 2007-2008 National Measles-Rubella Vaccination
Campaign: Implications for Rubella Elimination. J Infect Dis [Internet]. 2011
Sep 1 [cited 2018 Jan 24];204(suppl 2):S616–21. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21954256
22. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the
Health Belief Model. Health Educ Q [Internet]. 1988 [cited 2018 Jan
24];15(2):175–83. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/3378902
23. Carpenter CJ. A Meta-Analysis of the Effectiveness of Health Belief Model

33
Variables in Predicting Behavior. Health Commun [Internet]. 2010 Nov 30
[cited 2018 Jan 24];25(8):661–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21153982
24. Champion VL, Skinner CS. The Health Belief Model. In: Glanz K, Rimer
BK, Viswanath K, editors. Health Behavior and Health Education: Theories,
Research, and Practice. San Francisco, CA: Jossey Bass; 2008.
25. Lemeshow S. Adequacy of Sample Size in Health Studies. Geneva,
Switzerland: World Health Organization; 1990.

34
Biodata Anggota Peneliti

A. Identitas Diri
1 Nama Lengkap (dengan gelar) Lintang Dian Saraswati, SKM, M.Epid
2 Jenis Kelamin Perempuan
3 Jabatan Fungsional Lektor
4 NIP 198111042003122001
5 NIDN 0004118103
6 Tempat tanggal lahir Karanganyar, 4 November 1981
7 Email lintang.saraswati@live.undip.ac.id,
8 No telpon/HP 0246924422/08122916641
9 Alamat kantor FKM UNDIP, jalan Prof Sudharto SH
Tembalang Semarang
10 No telp/Faks 024760044/0247460044 ekstensi 102
11 Lulusan yang telah dihasilkan S1=80 orang, S2=6 orang, S3=0 orang
12 Mata Kuliah yang diampu 1. Isu Terkini Penyakit Tidak Menular
2. Survailans Kesehatan Masyarakat
3. Epidemiologi Penyakit Menular
4. Penyelidikan Wabah
5. Metodologi Penelitian
6. Metode Epidemiologi
7. Survei Epidemiologi
8. Epidemiologi Penyakit Tidak Menular
9. Dasar Epidemiologi
10. Epidemiologi KIA

B. Riwayat Pendidikan
S1 S2
Nama Perguruan Tinggi Universitas Diponegoro Universitas Indonesia
Bidang Ilmu Kesehatan Masyarakat, Epidemiologi, kekhususan
Peminatan Epidemiologi Epidemiologi Komunitas
Tahun Masuk-Lulus 1999-2003 2006-2008
Judul Peran PSN oleh Dasa Faktor risiko hepatitis kronis
skripsi/thesis/disertasi wisma dalam P3M DBD Pada tenaga kesehatan (studi
di RSDK 2008)
Nama dr. Ari Udijono, M.Kes DR. dr. Ratna Djuwita, MPH
pembimbing/promotor M. Arie Wuryanto, SKM, DR. dr. Tri Yunis Miko, MPH
M.Kes

C. Pengalaman Penelitian Dalam 5 TahunTerakhir


No Tahun Judul Penelitian Pendanaan
Sumber Jumlah
1 2013 Perbedaan gejala klinis dan gambaran PNBP 40
laboratories infeksi mycobacterium
2 2014 Skrining infeksi wuchereria bancrofti PNBP 40
berdasarkan status antigen Og3C4 di
daerah endemis filariasis
3 2014 Analisis Profil toleransi glukosa, respon Hibah 70
sitokin, dan status nutrisi pada infeksi Bersaing
Mycobacterium tuberculosis sebagai
model co management tuberkulosis-
4 2015 Identifikasi circulating filarial antigen dan Hibah 70
mikronutrien yang mempengaruhi status Fundamental
infeksi Wuchereria bancrofti
5 2015- Determinan Ko-Infeksi TB-HIV Sebagai RPP 65, 50
2016 Upaya Perbaikan Outcome Pengobatan Fase
Intensif
6 2015 Survei Coverage Pemberian Obat Masal Jarlitkes 10
Pencegahan (Pomp) Filariasis Limfatik di
Kota Pekalongan
7 2015 Responi mun seluler pada infeksi Wuchereria PNBP 40
bancrofti
8 2015 Prevalensi anemia dan kecacingan pada Mandiri 20
remaja putri di Kabupaten Rembang
9 2016 Rancang Bangun Cold Chain sebagai upaya PNBP 50
mempertahankan kualitas vaksin
10 2016- Integrated Biological And Behavioral PNBP 80
2017 Determinant To Improve Mass Drug
Administration And Quality Of Life: A
Longitudinal Study Of Lymphatic filariasis
11 2016 Faktor Risiko Penyakit Tular Darah di PNBP 36
Kabupaten Semarang
12 2017 Studi Prevalensi Penyakit Tular Darah di PNBP 22,5
Kabupaten Semarang
13 2017 Epidemiologi, diagnosis, dan upaya Preventif PUPT 100
promotif koinfeksi HIV dan TB pada anak

D. Pengalaman Pengabdian Kepada Masyarakat Dalam 5 Tahun Terakhir


No Tahun Judul Pengabdian Kepada Masyarakat Pendanaan
Sumber Jumlah
1 2013 Peningkatan pengetahuan dan praktik anak PNBP 6
sekolah dasar dalam pengendalian vector dbd
melalui intensifikasi kegiatan uks di kelurahan
endemis kota Semarang
2 2013 Pendampingan training of trainer bagi Tim WHO 180
Rencana Pengamanan Air Minum (RPAM)
Bandarharjo Kota Semarang
3 2014 Pengendalian Penyakit Menular Mandiri 1
(leptospirosis) berbasis komunitas di
Kabupaten Pati
4 2014 Peran Ekologi vector dan kompetensi PNBP 3
vector dalam penularan demam berdarah
dengue di KecamatanPedalangan
5 2014 Peningkatan Pengetahuan dan Praktik PNBP 15
Pencegahan Leptospirosis di Kelurahan
Pedalangan Kecamatan Banyumanik
6 2015 Deteksi Dini kehamilan risiko tinggi di Mandiri 1
Kelurahan Piyanggang Kecamatan
Sumowono)
7 2015 Epidemiologi penyakit dan PHBS pada anak Mandiri 1
SD Piyanggang 2 Kecamatan Sumowono
8 2015 Pengembangan sistem survailans DBD PNBP 15
berbasis sekolah
9 2016 Pendampingan Teknik Pengendalian Vektor PNBP 25
Berbasis Masyarakat Dalam Upaya Untuk
Menurunkan Kasus DBD Di Wilayah
Kelurahan Tembalang Semarang
10 2017 Sosialisasi DBD dan Program Satu Rumah PNBP 6
Satu Jumantik di PKK Kelurahan Tembalang

E. PublikasiArtikelIlmiahDalamJurnalDalam 5 TahunTerakhir
No JudulArtikel NamaJurnal Volume/Nomor/Tahun
1 Prevalens diabetes mellitus dan Kemas Jurnal Kesehatan 2014; 9(2): 106-210
tuberculosis paru Masyarakat.
2 Duration Of Type 2 Dm, Less Kesmas Indonesia Jurnal 2014; 7(1) : 12-21
Physical Activity, Irreguler Ilmiah Kesehatan
Medication, And Diabetic Diet Masyarakat
Non-adherence As Risk Factors (kesmasindo)
Of Chronic Complications
(Study In Type2 Diabetes
Mellitus/Niddm Patients At
Kudus District Hospital).
3 Elimination of Breeding Places Kesmas Indonesia Jurnal 2014; 7(1) :22-30
at School As a control of DHF Ilmiah Kesehatan
in Semarang. Masyarakat
(kesmasindo)
4 Risk assessment of Procedia 2015; 23: 93-98
Drinking Water Supply System Environmental
in the Tidal Inundation Area of Sciences
Semarang
5 Risk factors of hypertension in Makara Journal of Vol 19, No 2 (2015):
menopausal women in Health Research. 517
RejomulyoMadiun
6 Profileofglycated- Biomedical 2016; 39(5):354-360
hemoglobin, antioxidant vitamin Journals
and cytokinelevels in pulmonary
tuberculosis patients: A cross
sectional studyat Pulmonary
Diseases Center Semarang City,
Indonesia
7 Tuberculosis Worsen The Malaysian Journal 2017 (1), 151-156
Nutritional Status Of Hiv of Public Health
Patients If Unsupported By Medicine
Good Nutrition: A Cross
Sectional Study At Pulmonary
Diseases Center Semarang City,
Indonesia
8 The need of adequate IOP Conference Volume55, conf. 1
information to achieve total Series: Earth and http://iopscience.iop.org/ar
compliance of mass drug Environmental Science ticle/10.1088/1755-
administration in Pekalongan 1315/55/1/012059/meta
9 Environmental and Risk Factors IOP Conference Volume55, conf. 1
of Leptospirosis: A Spatial Series: Earth and Http://iopscience.Iop.Org/
Analysis in Semarang City Environmental Science Article/10.1088/1755-
1315/55/1/012013/Meta
10 Comparison Between TB-HIV Advanced Science 2017, 23, pp 3554–3557
Patients and HIV Patients: A Letter http://www.ingentaconnec
Cross-Sectional Study at t.com/contentone/asp/asl/2
Pulmonary Health Center 017/00000023/00000004/a
Semarang City, Indonesia rt00233
11 Soil-Transmitted Helminth Advanced Science 2017, 23, Pp 3565–3568
Infection in Elementary School Letter http://www.ingentaconnec
Children: An Integrated t.com/contentone/asp/asl/2
Environment and Behavior: 017/00000023/00000004/a
Case Study
District, in Bandungan
Semarang DistrictSub- rt00236
12 Factors associated with failure Advanced Science 2017, 23, Pp 3572–3575
of Conversion Among Letter http://www.ingentaconnec
Tuberculosis Patients t.com/contentone/asp/asl/2
017/00000023/00000004/a
13 Blood Glucose Profile Among Advanced Science 2017, 23, Pp 3614–3616
Adult Women in Semarang Letter http://www.ingentaconnec
t.com/contentone/asp/asl/2
017/00000023/00000004/a
14 A Mixed Method Study Of International Journal Of 2017, Vol 4 no 9
Tuberculosis Case Management Community Medicine http://www.ijcmph.com/in
In Hospitals Of West And And Public Health dex.php/ijcmph/article/vie
Central Java, Indonesia w/1782
15 Mapping Of Leptospirosis E3S Web of Conferences 2018, volume 31
Environmental Risk Factors and 31, 06003 (2018) https://doi.org/10.1051/e3s
Determining the Level of conf/20183106003
Leptospirosis Vulnerable Zone
In Demak District Using
Remote Sensing Image
16 The Presence Of Rat And House E3S Web of Conferences 2018, volume 31
Sanitation Associated With 31, 06008 (2018)
Leptospiras p. Bacterial https://doi.org/10.1051/e3s
Infection In Rats (A Cross conf/20183106008
Sectional Study In Semarang,
Central Java Province,
Indonesia)
17 Implementation of Water Safety IOP Conference Series: Volume 116, conference
Plans (WSPs): A Case Study in Earth and Environmental 1,\ 012029
the Coastal Area in Semarang Science doi :10.1088/1755-
City, Indonesia 1315/116/1/012029
18 Epidemiology of Child IOP Conference Series: Volume 116, conference
Tuberculosis (A Cross-Sectional Earth and Environmental 1, 012081
Study at Pulmonary Health Science doi :10.1088/1755-
Center Semarang City, 1315/116/1/012081
Indonesia)
19 Vaccines Cold Chain IOP Conference Series: Volume 116, conference
Monitoring: A Cross Sectional Earth and Environmental 1, 012082
Study at Three District In Science doi :10.1088/1755-
Indonesia 1315/116/1/012082

F. PemakalahSeminarIlmiah (Oral Presentation) Dalam 5 TahunTerakhir


No NamaPertemuan JudulArtikel WaktudanTempat
Ilmiah/Seminar Ilmiah
1 International Seminar and Characteristic, history of 29-30 Agustus 2013
Symposium Social diabetes mellitus and smoking Universitas Udayana
Determinants of Health- status among pulmonary Bali
The MDG’s and Beyond tuberculosis patients.
nd
2 2 ASEAN academic Household contact of 4-5 November 2013
society international pulmonary TB in Wonogiri Thailand
conference district, Central Java Province
3 2nd ASEAN academic Suspect Detection and Active 4-5 November 2013
society international Case Finding are important in Thailand
conference increasing case detection rate
:a comparison in high and low
tuberculosis CDR areas
3 International Seminar Mosquito’s bite prevention and 26 Oktober 2013
Integrated vector breeding places elimination Semarang
Management Health and may protect from DHF in
Environmental Perspectives Semarang 2012: a multivariate
analysis.
4 International symposium Practice of elimination of 29-30 November 2013
integrating research and breeding places in school UGM Yogyakarta
action on dengue society as a control of DHF in
Semarang.
5 International symposium Profile of Aedes Sp Based On 29-30 November 2013
integrating research and Index of Density and UGM Yogyakarta
action on dengue Transovarial Infection as A
Dengue Control
6 International Conference Risk assessment of drinking 12-13 Agustus 2014
Of Tropical and Coastal water supply system in the rob Semarang
Region Eco-Development area of Semarang
7 Seminar Nasional Manfaat Nutritional status comparison 29 September 2015
Studi Diet Total (SDT) of HIV patients and HIV Semarang
terhadap upaya peningkatan patient with Tuberculosis in
kesehatan gizi masyarakat SemarangCity, Central Java
Province, Indonesia
8 Seminar Ilmiah Nasional Hubungan keteraturan minum 28 Maret 2015
Kedokteran/Kesehatan: Obat dengan Konversi BTA Semarang
Capaian Target MDG’s Penderita Tuberkulosis Paru
2015, Pelayanan BTA positif (Studi Kohort
Kesehatan Primer dan Retrospektif di Balai
Sistem Rujukan, Kesehatan Paru Masyarakat
Pendidikan Kesehatan/ Semarang)
Kedokteran di Era
Jaminan Kesehatan
Nasional
9 Seminar Ilmiah Nasional Karakteristik Petugas dan 28 Maret 2015
Kedokteran/Kesehatan: Lingkungan Kerja yang terkait Semarang
Capaian Target MDG’s Pelaksanaan Surveilans
2015, Pelayanan Kesehatan Epidemiologi Malaria Tingkat
Primer dan Sistem Rujukan, Puskesmas di Kabupaten
Pendidikan Kesehatan/ Purworejo
Kedokteran di Era Jaminan
Kesehatan Nasional
10 Seminar Tantangan Prevalensi kecacingan di SDN 7 Desember 2015
Pendidikan Kesehatan 2 Wonokromo Kabupaten Semarang
dalam Pengembangan Semarang
Program pada Siklus
Kehidupan di Era SDG
11 International Conference Tuberculosis Worsen The 11-14 April 2016
on Environment and Nutritional Status Of Hiv Malaysia
Occupational Health Patients If Unsupported By
(ICEOH) Good Nutrition: A Cross
Sectional Study At Pulmonary
Diseases Center Semarang
City, Indonesia
12 International Conference on Comparison between TB-HIV 15-17 Oktober 2016
Public Health for Tropical Patients and HIV patients: A Semarang
and Coastal Development cross- sectional study at
(ICOPH- TCD 2016) Pulmonary Diseases Center
Semarang City, Indonesia
13 International Conference on Factors Associated With 15-17 Oktober 2016
Public Health for Tropical Failure of Conversion among Semarang
and Coastal Development Tuberculosis Patient
(ICOPH- TCD 2016)
14 International Conference on Soil-Transmitted Helminth 15-17 Oktober 2016
Public Health for Tropical Infection in Elementary Semarang
and Coastal Development School Children: An
(ICOPH- TCD 2016) Integrated Environment and
Behavior: Case Study in
Bandungan Sub- District,
Semarang District
15 International Conference Environmental and Behabioral 25-26 Oktober 2016
on Tropical and Coastal Risk Factors of Leptospirosis: Bali
Region Eco Development A Spatial Analysis in
(2nd ICTCRED 2016) Semarang City
16 International Conference The need of adequate 25-26 Oktober 2016
on Tropical and Coastal information to achieve total Bali
Region Eco Development compliance of mass drug
(2nd ICTCRED 2016) administration in Pekalongan
17 International Meeting of Risk factor for blood borne 19-20 November 2016
Public Health (2nd IMOPH disease (study in blood donor Jakarta
2016) at Semarang district)

18 The4th International One Effect of Density Variation of 3-7 December 2016


Health Congress & 6th Aedes aegypti Male Pupae in Melbourne
Biennial Congress of the Gamma Ray Radiation Media
International Association of 70Gy and Longevity Sterile
for Ecology & Health Male Mosquitoes Aedes
(OHEH 2016) aegypti(Linnaeus) to The Rate
of Eggs Produced Sterility
19 The 3rd ICTCRED Epidemiology of child 2-4 Oktober 2017
tuberculosis (a cross sectional Yogyakarta
study at Pulmonary Health
Center, Semarang City,
Indonesia)
20 The 3rd ICTCRED Vaccines cold chain 2-4 Oktober 2017
monitoring: a cross sectional Yogyakarta
study at three districts in
Indonesia
21 Sriwijaya International Prevalence of Blood Borne 5-6 Oktober 2017
Conference on Public Diseases in The Community Palembang
Health (SICPH) (A Cross Sectional Study in
The District of Semarang
22 International Conference on The Adherence of Taking 26-27 October 2017
Translational Medicine and Medicines with Conversion of Semarang
Health Sciences Acid Fast Bacillus of
Pulmonary Tuberculosis
Patients with Positive Acid
Fast Bacilli (Retrospective
Cohort Study In The Center
For Pulmonary Health
Semarang
23 Seminar Nasional Riset The Psychological and Social 25-26 October 2017
Tuberkulosis Impact of HIV infection Surakarta
associated with Childhood
Tuberculosis

G.Penghargaandalam10tahunTerakhir(daripemerintah,asosiasiatauinstitusilainnya
No JenisPenghargaan InstitusiPemberi Tahun
Penghargaan
1 Dosen berprestasi UNDIP 2013
2 Runner Up Best Oral Presenter in UGM 2013
International symposium integrating
research and action on dengue
3 Best Oral Presenter in ICEOH UPM (Universiti Putra Jaya) 2016
Malaysia
4 Best Poster Presentation in International UNDIP 2016
Conference on Public Health for Tropical
and Coastal Development (ICOPH-TCD
2016)
5 Satya Lencana 10 tahun Presiden Republik Indonesia 2016

H. DataBahan Ajar(Learning Materials Such As Books, Handouts, Etc)


No Jenis Judul Tahun Penerbit
1 Buku Ajar Dasar 2015 LP2MP Undip.
Epidemiologi ISBN: 978-602-1065-22-8
Jumlah halaman: 208
2 Buku Ajar Surveilans 2016 LP2MP Undip.
Epidemiologi ISBN: 978-602-1065-37-2
Jumlah halaman: 206

Semua data yang saya isikan dan tercantum dalam biodata ini adalah benar dan dapat
dipertanggungjawabkan secara hukum. Apabila di kemudian hari ternyata
dijumpai ketidak-sesuaian dengan kenyataan, saya sanggup menerima sanksi.
Demikian biodata ini saya buat dengan sebenarnya untuk memenuhi salah
satu persyaratan dalam pengajuan PDUPT 2018.

Semarang, 23 Maret 2018

Lintang Dian Saraswati, SKM, M.Epid


NIP. 198111042003122001
NIDN. 0004118103
Biodata Anggota Peneliti

A. Identitas
1 Nama Lengkap Praba Ginandjar, SKM, M.Biomed
2 Jenis kelamin Perempuan
3 Jabatan fungsional Lektor Kepala
4 NIP 197109041997022004
5 NIDN 004097102
6 Tempat dan tanggal lahir Purbalingga, 4 September 1971
7 Email praba.ginandjar@live.undip.ac.id
8 Nomor HP 081325887942
9 Alamat kantor Jl. Prof. Sudarto SH, Kampus UNDIP Tembalang,
Semarang 50275
10 Nomor telepon 024-7460044
11 Lulusan yang telah S1: orang
dihasilkan S2: orang
12 Mata kuliah yang diampu 1. Dasar epidemiologi
2. Dasar biomedik 2
3. Vaksin imun
4. Penyakit tropik
5. Epidemiologi KIA
6. Penulisan ilmiah
7. Penyakit tular vektor

B. Riwayat pendidikan
S1 S2
Nama Perguruan Universitas Diponegoro Universitas Indonesia
Tinggi
Bidang Ilmu Epidemiologi Biomedik
Tahun Masuk-Lulus 1990-1995 2000-2003
Judul GAKI Deteksi IgG4 anti-filaria
Skripsi/Tesis/Disertasi dengan brugia rapid test pada
daerah endemis Brugia
malayi di Pulau Alor, NTT
Nama dr. R. Djoko Nugroho, Prof. Taniawati Supali, PhD
Pembimbing/Promotor M.Kes

C. Pengalaman penelitian lima tahun terakhir


No Tahun Judul penelitian Pendanaan
Sumber Jumlah (Rp)
1 2017 Studi Prevalensi Penyakit Tular PNBP 22.500.000
Darah di Kabupaten Semarang
2 2017 Epidemiologi, diagnosis, dan upaya PUPT 100.000.000
Preventif promotif koinfeksi HIV
dan TB pada anak
3 2016 Integrated biological and PNBP Undip 80.000.000
behavioral determinant to improve (RPI)
mass drug administration and
quality of life: A longitudinal
study of lymphatic filariasis
4 2016 Penelitian Lanjutan: PNBP Undip 60.000.000
Determinan Ko-Infeksi TB-HIV (RPP)
Sebagai Upaya Perbaikan
Outcome Pengobatan Fase Intensif
5 2015 Identifikasi circulating filarial Ditlitabmas 66.000.000
antigen dan mikronutrien yang Dikti (Hibah
mempengaruhi status infeksi Fundamental)
Wuchereria bancrofti
6 2015 Determinan Ko-Infeksi TB-HIV PNBP Undip 65.000.000
Sebagai Upaya Perbaikan (RPP)
Outcome Pengobatan Fase Intensif
7 2015 Survei coverage pemberian obat Dinkesprov 10.000.000
masal pencegahan (POMP) filariasis Jateng
limfatik di Kota Pekalongan (Jarlitkes)
8 2014 Skrining infeksi Wuchereria PNBP FKM 40.000.000
bancrofti di daerah endemis
filariasis
9 2014 Analisis profil toleransi glukosa, Ditlitabmas 70.000.000
respon sitokin, dan status nutrisi Dikti (Hibah
pada infeksi Mycobacterium Bersaing)
tuberculosis sebagai model co-
management tuberkulosis-diabetes
10 2014 Profil hemoglobin, intensitas Mandiri
infeksi, distribusi dan determinan
Soil transmitted Helminth pada
remaja putri di Kabupaten Rembang
11 2013 Perbedaan gejala klinis dan FKM 40.000.000
gambaran laboratoris infeksi
Mycobacterium tuberkulosis
berdasarkan statuskontrol glukosa
darah

D. Pengalaman pengabdian kepada masyarakat lima tahun terakhir


No Tahun Judul pengabdian kepada masyarakat Pendanaan
Sumber Jumlah (Rp)
1 2017 Sosialisasi DBD dan Program Satu PNBP 6
Rumah Satu Jumantik
2 2016 Pendampingan Teknik Pengendalian PNBP 25
Vektor Berbasis Masyarakat
Dalam Upaya Untuk
Menurunkan Kasus DBD di
Wilayah Kelurahan Tembalang
Semarang
3 2015 Pengembangan sistem survailans PNBP 15.000.000
DBD berbasis sekolah
4 2015 Pelatihan surveilan DBD pada PNBP 15.000.000
masyarakat sekitar sekolah di
Kecamatan Tembalang
5 2014 Sosialisasi teknik-teknik FKM 3.000.000
pengendalian tikus
6 2014 Pengenalan tikus sebagai reservoir FKM 3.000.000
penyakit
7 2013 Pendampingan training of trainer bagi WHO 180.000.000
Tim Rencana Pengamanan Air
Minum (RPAM) Bandarharjo
8 2013 IBM Sosialisasi Bionomik Vektor BOPTN 5.000.000
DBD pada ibu PKK di wilayah
endemis kota Semarang
9 2012 Kampanye motivasi dan edukasi HIV BOPTN 5.000.000

E. Publikasi ilmiah dalam jurnal lima tahun terakhir


No Tahun Judul artikel Nama jurnal Vol
(Nomor);
1 2017 Implementation of Water Safety Plans IOP Conference Volume 116,
(WSPs): A Case Study in the Coastal Area Series: Earth and conference 1,\
in Semarang City, Indonesia Environmental 012029
Science
2 2017 Epidemiology of Child Tuberculosis (A IOP Conference Volume 116,
Cross-Sectional Study at Pulmonary Series: Earth and conference 1,
Health Center Semarang City, Indonesia) Environmental 012081
Science
3 2017 Vaccines Cold Chain Monitoring: A Cross IOP Conference Volume 116,
Sectional Study at Three District In Series: Earth and conference 1,
Indonesia Environmental 012082
Science
4 2016 Profile of glycated-hemoglobin, Biomedical Will be
antioxidant vitamin and cytokine levels in Journal published on
pulmonary tuberculosis patients: A cross October
sectional study at Pulmonary Diseases 2016
Center Semarang City, Indonesia
5 2015 Risk assessment of drinking water supply Procedia 23: 93-98,
system in the tidal inundation area of Environmental doi: 10.1016/
Semarang – Indonesia Sciences j.proenv.2015
6 2014 Duration of type 2 DM, less physical Kesmas 7 (1): 12-21
activity, irreguler medication, and Indonesia Jurnal
diabetic diet nonadherence as risk factors Ilmiah
of chronic complications: A study in type Kesehatan
2 DM/NIDDM patients at Kudus District Masyarakat
Hospital (Kesmasindo)
7 2013 Tidak ada perbedaan respon imun Jurnal Gizi 2 (1) : 12-14
perokok berat dan perokok ringan karena Indonesia
asupan mikronutrien
8 2013 The effect of zinc and vitamin C The Southeast 44 (5): 733-
supplementation on hemoglobin and Asian Journal of 739
hematocrit levels and immune response Tropical
in patients with plasmodium vivax Medicine and
malaria Public Health

F. Pemakalah ilmiah lima tahun terakhir


No Nama pertemuan Judul artikel Waktu dan tempat
ilmiah/seminar
1 Sriwijaya International Analysis of Community October 5-6 2017
Conference on Public Health Compliance Toward MDA in at Arya Duta Hotel
(SICPH) Filariasis Endemic Sub District Palembang.
Pekalongan
2 Seminar Nasional Tantangan Identifikasi circulating filarial Semarang, 7
Pendidikan Tinggi dalam antigen dan mikronutrien pada Desember 2015
Pengembangan Program pada anak sekolah dasar Kabupaten
Siklus Kehidupan di Era Pekalongan
SDG’s.
3 Seminar Tantangan Prevalensi kecacingan di SDN 2 Semarang, 7
Pendidikan Kesehatan dalam Wonokromo Kabupaten Desember 2015
Pengembangan Program pada Semarang
Siklus Kehidupan di Era
SDG
4 Seminar Nasional Manfaat Nutritional status comparison of Semarang, 29
Studi Diet Total (SDT) HIV patients and HIV patient September 2015.
terhadap upaya peningkayan with Tuberculosis in Semarang Prosiding ISBN:
kesehatan gizi masyarakat City, Central Java Province, 979-26-0279-8
Indonesia
5 Seminar Ilmiah Nasional Hubungan keteraturan minum Semarang, 28
Kedokteran/Kesehatan: Obat dengan Konversi BTA Maret 2015
Capaian Target MDG’s 2015, Penderita Tuberkulosis Paru BTA
Pelayanan Kesehatan Primer positif (Studi Kohort Retrospektif
dan Sistem Rujukan, di Balai Kesehatan Paru
Pendidikan Kesehatan/ Masyarakat Semarang)
Kedokteran di Era Jaminan
Kesehatan Nasional
6 International Conference of Risk assessment of drinking Semarang, 12-13
Tropical and Coastal Region water supply system in the rob Agustus 2014
Eco-Development area of Semarang
7 Seminar Nasional Penyakit Status gizi yang terkait Denpasar, 12-13
Tidak Menular, hipertensi pada kehamilan September 2014
8 Asean Academic Society Suspect detection and Bangkok, 4-5
International Conference active case finding are important November 2013
in increasing case detection rate
(CDR): a comparison in high
and low tuberculosis CDR areas
9 Asean Academic Society Household contact of Bangkok, 4-5
International Conference pulmonary tuberculosis in November 2013
Wonogiri District, Central Java
Province, Indonesia
10 International seminar on Mosquitos bite prevention and Semarang, 26
Integrated Vector breeding places elimination may Oktober 2013
Management: Health and protect from DHF in Semarang
Environmental Perspectives
11 International seminar and Inappropriate immunization Denpasar, 29-30
symposium: Social practice in diphteria outbreak Agustus 2013
determinant of health areas of Semarang

G. Penghargaan dalam 10 tahun Terakhir (dari pemerintah, asosiasi atau institusi


lainnya)
No JenisPenghargaan InstitusiPemberi Tahun
Penghargaan
1 Dosen berprestasi UNDIP 2012
2 Satya Lacana Presiden RI 2013

Semua data yang saya isikan dan tercantum dalam biodata ini adalah benar dan dapat
dipertanggungjawabkan secara hukum. Apabila di kemudian hari ternyata dijumpai
ketidak-sesuaian dengan kenyataan, saya sanggup menerima sanksi.
Demikian biodata ini saya buat dengan sebenarnya untuk memenuhi salah satu
persyaratan dalam pengajuan PDUPT 2018.

Semarang, 23 Maret 2018


Peneliti,

Praba Ginandjar, SKM, M.Biomed


NIP. 197109041997022004
NIDN. 0004097102
Biodata Anggota Penelitian
A. Identitas Diri
No. Uraian Keterangan

1. Nama Lengkap & Gelar Nissa Kusariana SKM., M.Si.

2 Jenis Kelamin P

3 Jabatan Fungsional -

4. NIP 198910310117012076

5. NIDN 0731108901

6. Tempat & Tanggal lahir Salatiga, 31 Oktober 1989

7. Email nissakusariana@gmail.com

8. Nomor Telpon/HP/Faks. 081319305831


Rumah

9. Alamat & No. Tlp/Faks. Jl. Prof. Sudarto, SH, Tembalang, Semarang
Kantor 024 7460044/ Fax.024 7460044 ext 102

10. Lulusan yang telah -


dihasilkan

11 Mata Kuliah yang Diampu 1. Morfologi dan Taksonomi Serangga

2. Penyakit Tular Vektor

3. Dasar Epidemiologi

4. Penyakit Tropik

5. Epidemiologi Penyakit Tidak Menular

6. Entomologi Kesehatan

7. Teknik Entomologi

B. Riwayat Pendidikan :
Keterangan S1 S2
Nama Perguruan Tinggi Universitas Diponegoro IPB

Bidang Ilmu Kesehatan Masyarakat Parasitologi &


Entomologi Kesehatan

Tahun Masuk 2006 2011

Tahun Keluar 2010 2013

Judul Skripsi/Tesis/Disertasi Analisis Kewilayahan Uji Resistensi Tiga


Kepadatan Larva dan Golongan Insektisida
Sosiodemografi dengan Terhadap Tiga Isolat
Kejadian Penyakit Demam Lalat Rumah Musca
Berdarah Dengue (DBD) di domestica (Diptera:
Kota Salatiga pada Tahun Muscidae) di Bogor
2008-2009
Nama Pembimbing/Promotor Dra. Retno Hestiningsih, Dr. drh. Dwi Jayanti
M.Kes Gunandini, M.Si

C. Riwayat Penelitian
No. Tahun Judul Penelitian Pendanaan
Sumber Jumlah
- - - - -

D. Riwayat Pengabdian
No Tahun Judul Pengabdian Kepada Masyarakat Pendanaan
. Sumber Jumlah
- - - - -

E. Pengalaman Penulisan Artikel Ilmiah Dalam Jurnal


No. Tahun Judul Artikel Ilmiah Volume/ Nama Jurnal
Nomor
- - - - -

F. Pemakalah dalam Seminar Ilmiah


No Tahun Judul Materi Pemakalah Keterangan
.
1 2017 Self-Effieacy in Positive Sexual Oral International Conference on
Behavior among Students Presentation Public Health 2017
Participating in the Center for Penyelenggara : Program
Information and Counseling Pascasarjana Univ. Sebelas
of Reproductive Heahh in Maret
Madiun
2 2017 Entomology status based on Oral Sriwijaya International
vector density index and Presentation Conference on Public
transovarial infection in Aedes Health
sp. as a dengue vector in Penyelenggara : FKM
meteseh sub-district semarang Universitas Sriwijaya
city
CURRICULUM VITAE

PERSONAL IDENTITY

Full Name : PUTRI SEPTYARINI

Place / Date of Birth : REMBANG, SEPTEMBER 14th 1992

Sex : FEMALE

Religion : MOSLEM

Marital Status : SINGLE

Address : GEDONGMULYO VILLAGE RT04 RW03, LASEM

Post Code : 59271

Citizenship : INDONESIAN

Phone Number : 085225676238 / 089605020465

Email Address : putriseptya140992@gmail.com


GPA : 3.43 (Scale 4.00)
Tittle of Thesis : Survey Risk Factors of Non Communicable Disease in Rembang Regency ( Stepwise
WHO Analysis)
voluunteer)
T
WORK PRACTICE EXPERIENCE

COMPANY POSITIONS YEAR


DEPARTMENT OF
EPIDEMIOLOGY AND
TROPICAL DISEASE, PUBLIC RESEARCH ASSISTANT 2017-NOW
HEALTH FACULTY,
DIPONEGORO UNIVERSITY

DISTRICT HEALTH OFFICE


HEALTH SURVEILLANCE STAFF 2016
OF SEMARANG

FORMAL EDUCATION

Year
Name of Institution Location Faculty/Majoring Result
In Out
MASTER OF
EPIDEMIOLOGY,
2018 SEMARANG EPIDEMIOLOGY ON GOING
POSTGRADUATE SCHOOL,
DIPONEGORO UNIVERSITY

PUBLIC HEALTH /
2010 2014 DIPONEGORO UNIVERSITY SEMARANG EPIDEMIOLOGY AND GRADUATED
TROPICAL DISEASE
2007 2010 SMA NEGERI 1 REMBANG REMBANG SCIENCE GRADUATED

2004 2007 SMP NEGERI 1 LASEM REMBANG - GRADUATED

SD NEGERI
1998 2004 REMBANG - GRADUATED
DOROKANDANG 1

SKILLS

GOOD IN TEAMWORK
SKILLS
MICROSOFT WINDOWS BASED OPERATING SYSTEM, MICROSOFT OFFICE (MS WORD, MS EXCEL,
POWER POINT)
FAMILIAR WITH FIRST AID

ABLE TO OPERATE SPSS AND EPI INFO 7

LANGUAGE
UNDERSTAND COMMUNICATION IN ENGLISH, BOTH ORAL AND WRITTEN
PROFICIENCY

ORGANIZATION EXPERIENCES

YEAR ORGANIZATION / EVENTS

2012 GENERAL STAF OF SCHOLARSHIP DIVISON KESMA BEM KM UNDIP 2012

2012 STAF OF LOGISTIC DIVISON KSR PMI UNIT UNDIP


2012 COMMITTEE OF DIKLATSAR KSR PMI UNIT UNDIP
2012 COMMITTEE OF “BAKTI SOSIAL” KSR PMI UNIT UNDIP

2011 COMMITTEE OF “PEKAN ILMIAH MAHASISWA” UNDIP 2011

Seminary
Year Organizer / Institution
PARTICIPANT OF INTERNATIONAL SEMINARY UNDIP- PUBLIC HEALTH FACULTY OF
2017
TUFTS UNIVERSITY: ONE HEALTH AND ZOONOSIS DIPONEGORO UNIVERSITY
PARTICIPANTS OF THE INTERNATIONAL SEMINARY PUBLIC HEALTH FACULTY OF
2013
UNDIP-UNIVERSITY OF QUEENSLAND JOINT SEMINAR DIPONEGORO UNIVERSITY
22013 : RESEARCH FOR POLICY COMMUNITY
HEALTH-INSIGHT FROM RESENT
PARTICIPANTS OF THE NATIONAL SEMINARY YOUNG ON
TOP ENTERPREUNERSHIP SEMINAR “SMART CHANGE IN 2012 BNI
YOUR LIFE”
PARTICIPANTS OF THE NATIONAL SEMINARY AND TALK
FACULTY OF MEDICINE DIPONEGORO
SHOW “ MAKING POSITIVE CHANGE, STRESS FREE FOR 2012
UNIVERSITY
HEALTHIER LIFE”
PARTICIPANTS OF THE NATIONAL SEMINARY “WORLD PUBLIC HEALTH FACULTY OF
2012
FIT FOR CHILDREN” DIPONEGORO UNIVERSITY
PARTICIPANTS OF THE NATIONAL SEMINARY
2011 DIPONEGORO UNIVERSITY
“SCHOLARSHIP SHOW 2011”
PARTICIPANTS OF THE NATIONAL SEMINARY “SEHAT PUBLIC HEALTH FACULTY OF
2011
ISTRIKU, SEHAT IBUKU, INDONESIAKU” DIPONEGORO UNIVERSITY
PARTICIPANTS OF THE NATIONAL SEMINARY ON
OCCUPATIONAL AND SAFETY “THE APLICATION OF OSH
2011 OSH FORUM FKM UNDIP
PROFESSION IN INDUSTRY AND OSH CULTURE IN
CONSTRUCTION SERVICE”

TRAINING & COURSE

Training and Course Year Organizer / Institution


TRANING OF PERSONALITY AND ETHICS STUDENT BEM PUBLIC HEALTH FACULTY OF
2011
COLLEGE DIPONEGORO UNIVERSITY
PRE BASIC TRAINING LEADERSHIP FOR COLLEGE
BEM PUBLIC HEALTH OF DIPONEGORO
STUDENT (LATIHAN KETRAMPILAN MAHASISWA TINGKAT 2010
UNIVERSITY
PRA DASAR)

TRAINING “DIKLATSAR KSR PMI UNIT FKM UNDIP” 2010 KSR UNIT FKM UNDIP

PUBLIC HEALTH FACULTY OF


TRAINING “ PENULISAN KARYA TULIS ILMIAH” 2010
DIPONEGORO UNIVERSITY
CURRICULUM VITAE


Data Pribadi
Nama Lengkap : Endang Sri Utami
Nama Panggilan : Endang
Tempat, Tanggal Lahir : Pemalang, 13 Mei 1994
Angkatan : 2013
Fakultas / Jurusan : Kesehatan Masyarakat
Jenis Kelamin : Perempuan
Golongan Darah : AB
Semester : VII
Alamat Asal : Jl. Salak No. 26 RT 03/I Kraton, Kota Tegal
Alamat Sekarang : Jl. Sumurboto 2 No 13 RT 05/03 Banyumanik, Semarang
No HP : 085712563613 / 085225695352
Alamat E-mail : endangsriutami13@gmail.com
Motto Hidup : Man Jadda Wa Jadda


Pendidikan Formal :
Sekolah – Universitas Tahun
Kesehatan Masyarakat – Universitas Diponegoro 2017
SMA Negeri 1 Kota Tegal 2013
SMP Negeri 7 Kota Tegal 2010
SD Negeri Tegalsari 8 Kota Tegal 2007


Organisasi dan Pengembangan Softskill yang Pernah Di Ikuti:
Lembaga Departemen Jabatan Tahun
Penalaran Ilmiah Research
Club (PIRC) FKM Non Divisi Direktur 2016
Humas (Supporting
FKM Undip Wadek 4 FKM Undip) Tim 2016
Penalaran Ilmiah Research
Club (PIRC) FKM Edukasi Manager 2015
Penalaran Ilmiah Research
Club (PIRC) FKM Edukasi Staf Muda 2014
Keluarga Mahasiswa Islam
(Gamais) FKM Humas Staf Muda 2014

Pelatihan dan Seminar yang Pernah di Ikuti

Nama Kegiatan Lembaga Penyelenggara Tahun


Seminar Nasional Technopreneurship HMM PSD Teknik Mesin Undip 2015
Seminar Nasional HKN "Modernisasi BEM Undip 2014
Edukasi Seks
LKMM D BEM FKM Undip 2014
Seminar Nasional Kewirausahaan BEM Undip 2014
Diponegoro Entrepreneur Festival
PMB PK BEM FKM Undip 2013
LKMM PD BEM FKM Undip 2013
LKTI BEM FKM Undip 2013
Surveilens KIA BEM FKM Undip 2013
SOS (School of Speaking) BEM FKM Undip 2013
Diklatsar KSR FKM Undip 2013
Talkshow Bulan Kesehatan Jawa BEM FKM Undip 2013
Tengah
Seminar International Education Fair BEM Undip 2013
Seminar, Talkshow, Dan Training BEM FKM Undip 2013
Motivasi PHaSE


Prestasi yang Pernah Diraih :
Nama Lomba/Event Penyelenggara Urutan Tahun
Public Health Paper Competition FKM UNDIP Juara 3 2015
Hibah Penelitian Mahasiswa UNDIP Lolos didanai 2015
Inovation Engineering Society ITS Finalis 5 Besar 2015
Hibah Pemberdayaan dan MITI Lolos didanai 2015
Pengabdian Masyarakat
Hibah Penelitian Mahasiswa UNDIP Lolos didanai 2014

Kepanitiaan Yang Pernah di Ikuti

Nama Kegiatan/Event Penyelenggara Jabatan Tahun


International Conference on Public
Helath for Tropical and Coastal Scientific’s
Development (ICOPH-TD 2016) FKM Undip division 2016
Seminar Nasional “Tantangan
Pendidikan Tinggi Kesehatan dalam
Pengembangan Program Pada Siklus
Kehidupan di Era SDG’s” FKM Undip Sekretaris 2015

LKTI Nasional Masterpiece PIRC FKM Undip Ketua Panitia 2015


LKMMD BEM FKM Undip Sie Danus 2015
Study Club 2 PIRC FKM Undip Sie Logistik 2015
Study Club 1 PIRC FKM Undip Sie Humas 2015
Grand Opening Mawapres FKM Undip Ketua Panitia 2014
Study Club PIRC FKM Undip Ketua Panitia 2014
GIF (Gamais Islamic Fair) Gamais FKM Undip Sie Humas 2014
Gerakan Desa Cinta Lingkungan BEM FKM Undip Sie Konsumsi 2014
Donor Darah IMASSTE Sie Konsumsi 2014
PhaSE BEM FKM Undip Sie Humas 2014
Pelatihan Paper dan KTI “Masterpiece” PIRC FKM Undip Sie Acara 2014
Study Club PIRC FKM Undip Sie Konsumsi 2013